首页> 外文期刊>Journal of International Medical Research >Thrombus aspiration during primary percutaneous coronary intervention improved outcome in patients with STEMI and a large thrombus burden
【24h】

Thrombus aspiration during primary percutaneous coronary intervention improved outcome in patients with STEMI and a large thrombus burden

机译:血栓吸汗在原发性经皮冠状动脉介入期间改善了STEMI和大血栓负担的患者的结果

获取原文
           

摘要

Background The benefit of thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) to patients with ST-segment elevation myocardial infarction (STEMI) remains controversial. This study aimed to assess TA's impact on the outcome and prognosis for patients with STEMI and a large thrombus burden during PPCI. Methods This retrospective study evaluated consecutive patients with STEMI and a large thrombus burden (thrombolysis in myocardial infraction [TIMI] thrombus grade ≥4) who underwent conventional PPCI (n?=?126) or PPCI?+?TA (n?=?208) between February 2017 and January 2019. The procedure outcome and clinical prognosis were compared. Results Postprocedural vessel diameter was larger, and corrected TIMI frame count (cTFC) was lower in the PPCI?+?TA compared with the PPCI group. The proportion of postprocedural TIMI 3 flow was 83.3% in the PPC group and 94.2% in the PPCI+TA group. During the 12-month follow-up, no significant differences existed in the incidence of cardiac death, reinfarction, stent thrombosis, target vessel revascularization, or stroke. Conclusion Application of TA in patients with STEMI and a large thrombus burden during PPCI may improve the procedural outcome, but it showed no benefit on the clinical prognosis in the 12-month follow-up. Longer follow-up studies are needed to confirm TA's clinical implications in patients with STEMI.
机译:背景技术血栓吸汗(TA)在初生经皮冠状动脉干预(PPCI)期间对ST段抬高心肌梗死(Stemi)的患者仍存在争议。本研究旨在评估TA对PPCI患者患者的结果和预后的影响。方法该回顾性评估患有STEMI的连续患者和大型血栓负担(心肌梗死溶栓[TIMI]血栓≥4),其接受常规PPCI(n?= 126)或PPCI?+?ta(n?=?208 )2017年2月和2019年1月。比较程序结果和临床预后。结果后预先形成血管直径较大,并且与PPCI组相比,PPCIα+α校正的TiMi帧数(CTFC)较低。 PPC基团的后期后3流量的比例为83.3%,PPCI + TA组中的94.2%。在12个月的随访期间,心脏死亡,重新衰退,支架血栓形成,靶血管血运重建或中风的发生率没有显着差异。结论TA在PPCI期间TA与大血栓负担患者的应用可能改善程序结果,但它显示出12个月随访中的临床预后没有益处。需要更长的后续研究来证实Stemi患者的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号